Tezosentan
- Generic Name
- Tezosentan
- Drug Type
- Small Molecule
- Chemical Formula
- C27H27N9O6S
- CAS Number
- 180384-57-0
- Unique Ingredient Identifier
- 64J9J55263
Overview
Tezosentan is an intravenous endothelin receptor A/B antagonist. Tezosentan was initially developed for vasodilation in patients with acute heart failure but studies have shown that it does not assist in the treatment of dyspnea or prevent cardiovascular events.
Background
Tezosentan is an intravenous endothelin receptor A/B antagonist. Tezosentan was initially developed for vasodilation in patients with acute heart failure but studies have shown that it does not assist in the treatment of dyspnea or prevent cardiovascular events.
Indication
Investigated for use/treatment in congestive heart failure, liver disease, and heart disease.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath